Paclitaxel Treatment Options in Canada

A collection of 342 research studies where Paclitaxel is the interventional treatment. These studies are located in the Canada . Paclitaxel is used for conditions such as Breast Cancer, Ovarian Cancer and Non-Small Cell Lung Cancer.

Home

Canada

All Treatments

Paclitaxel

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin

NCT01285609

Completed

The purpose of the study is to determine whether Ipilimumab plus Paclitaxel and Carboplatin will extend the lives of patients with squamous only non small cell lung cancer more than placebo plus Paclitaxel and Carboplatin.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/16/2020

Locations: Sharp Memorial Hospital, San Diego, California +289 locations

Sharp Memorial Hospital, San Diego, California

Va Connecticut Healthcare System, West Haven, Connecticut

Lynn Cancer Institute Center For Hematology-Oncology, Boca Raton, Florida

Integrated Community Oncology Network, Jacksonville, Florida

University Of Illinois At Chicago Medical Center, Chicago, Illinois

Quincy Medical Group, Quincy, Illinois

Presence Medical Group Hematology Oncology, Skokie, Illinois

Southern Illinois University School Of Medicine, Springfield, Illinois

St. Francis Hospital & Health Centers, Indianapolis, Indiana

Floyd Memorial Cancer Center Of Indiana, New Albany, Indiana

Kentucky Cancer Clinic, Hazard, Kentucky

Norton Cancer Institute, Louisville, Kentucky

Montgomery Cancer Center, Mount Sterling, Kentucky

St Joseph Mercy Hospital, Ypsilanti, Michigan

University Of Kansas Cancer Center, Kansas City, Missouri

Washington University School Of Medicine, Saint Louis, Missouri

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

Clinical Research Alliance, Inc., Lake Success, New York

Durham Va Medical Center (111g), Durham, North Carolina

Carolina Biooncology Institute, Huntersville, North Carolina

Novant Health Oncology Specialists, Lexington, North Carolina

Gabrail Cancer Center Research, Canton, Ohio

Oklahoma Oncology And Hematology, Pc Dba, Tulsa, Oklahoma

Kaiser Permanente Northwest Region, Portland, Oregon

Guthrie Medical Group, P.C., Sayre, Pennsylvania

Wjb Dorn Va Medical Center, Columbia, South Carolina

Cancer Center Of The Carolinas, Greenville, South Carolina

Associated in Oncology and Hematology, Chattanooga, Tennessee

Tennessee Cancer Specialists, Knoxville, Tennessee

Thompson Oncology Group, Knoxville, Tennessee

Texas Oncology, PA - South Austin Cancer Center, Austin, Texas

Blue Ridge Cancer Care, Blacksburg, Virginia

Wisconsin Institutes for Medical Research, Madison, Wisconsin

Local Institution, Quilmes, Buenos Aires

Local Institution, Rosario, Santa FE

Local Institution, San Miguel De Tucuman, Tucuman

Local Institution, Cordoba, Not set

Local Institution, Mendoza, Not set

Local Institution, Santa Fe, Not set

Local Institution, Bedford Park, South Australia

Local Institution, Box Hill, Victoria

Local Institution, Frankston, Victoria

Local Institution, Heidelberg, Victoria

Local Institution, Wodonga, Victoria

Local Institution, Graz, Not set

Local Institution, Linz, Not set

Local Institution, Salzburg, Not set

Local Institution, Aalst, Not set

Local Institution, Liege, Not set

Local Institution, Sint Niklaas, Not set

Local Institution, Yvoir, Not set

Local Institution, Fortaleza, Ceara

Local Institution, Belo Horizonte, Minas Gerais

Local Institution, Curitiba, Parana

Local Institution, Passo Fundo, RIO Grande DO SUL

Local Institution, Barretos, SAO Paulo

Local Institution, Sao Jose dos Campos, SAO Paulo

Local Institution, Porto Alegre, Not set

Local Institution, Ribeirao Preto, Not set

Local Institution, Rio de Janeiro, Not set

Local Institution, Sao Paulo, Not set

Local Institution, Montreal, Quebec

Local Institution, Oshawa, Not set

Local Institution, Santiago, Metropolitana

Local Institution, Vina Del Mar, Valparaiso

Local Institution, Guangzhou, Guangdong

Local Institution, Guanzhou, Guangdong

Local Institution, Shantou, Guangdong

Local Institution, Wuhan, Hubei

Local Institution, Nanjing, Jiangsu

Local Institution, Suzhou, Jiangsu

Local Institution, Changchun, Jilin

Local Institution, Xi'an, Shaanxi

Local Institution, Urumqi, Xinjiang

Local Institution, Hangzhou, Zhejiang

Local Institution, Beijing, Not set

Local Institution, Santiago, Not set

Local Institution, Shanghai, Not set

Local Institution, Monteria, Cordoba

Local Institution, Pereira, Risaralda

Local Institution, Ostrava, Poruba

Local Institution, Prague 2, Not set

Local Institution, Praha 5, Not set

Local Institution, Praha 8, Not set

Local Institution, Pribram V-Zdabor, Not set

Local Institution, Usti Nad Labem, Not set

Local Institution, Znojmo, Not set

Local Institution, Aalborg, Not set

Local Institution, Herlev, Not set

Local Institution, Hillerod, Not set

Local Institution, Naestved, Not set

Local Institution, Odense, Not set

Local Institution, Caen Cedex 05, Not set

Local Institution, Marseille Cedex 20, Not set

Local Institution, Paris, Not set

Local Institution, Poitiers, Not set

Local Institution, Rennes Cedex 9, Not set

Local Institution, Toulouse Cedex 9, Not set

Local Institution, Vandoeuvre-les-nancy, Not set

Local Institution, Bad Berka, Not set

Local Institution, Bochum, Not set

Local Institution, Darmstadt, Not set

Local Institution, Dresden, Not set

Local Institution, Frankfurt Am Main, Not set

Local Institution, Gauting, Not set

Local Institution, Grosshandsdorf, Not set

Local Institution, Hamburg, Not set

Local Institution, Heidelberg, Not set

Local Institution, Kassel, Not set

Local Institution, Lubeck, Not set

Local Institution, Mainz, Not set

Local Institution, Muenchen, Not set

Local Institution, Neumunster, Not set

Local Institution, Nuernberg, Not set

Local Institution, Regensburg, Not set

Local Institution, Tuebingen, Not set

Local Institution, Ulm, Not set

Local Institution, Villingen-Schwenningen, Not set

Local Institution, Hong Kong, Not set

Local Institution, New Territories, Not set

Local Institution, Budapest, Not set

Local Institution, Deszk, Not set

Local Institution, Farkasgyepu, Not set

Local Institution, Gyula, Not set

Local Institution, Matrahaza, Not set

Local Institution, Nyiregyhaza, Not set

Local Institution, Pecs, Not set

Local Institution, Sopron, Not set

Local Institution, Szekesfehervar, Not set

Local Institution, Szolnok, Not set

Local Institution, Dublin, Not set

Local Institution, Galway, Not set

Local Institution, Beer Sheva, Not set

Local Institution, Haifa, Not set

Local Institution, Jerusalem, Not set

Local Institution, Nahariya, Not set

Local Institution, Petah-Tikva, Not set

Local Institution, Rehovot, Not set

Local Institution, Tel Aviv, Not set

Local Institution, Tel-aviv, Not set

Local Institution, Tel-hashomer, Not set

Local Institution, Zerifin, Not set

Local Institution, Benevento, Not set

Local Institution, Bologna, Not set

Local Institution, Lido Di Camaiore, Not set

Local Institution, Lucca, Not set

Local Institution, Monza, Not set

Local Institution, Padova, Not set

Local Institution, Perugia, Not set

Local Institution, Siena, Not set

Local Institution, Sondrio, Not set

Local Institution, Terni, Not set

Local Institution, Treviglio, Not set

Local Institution, Nagoya-shi, Aichi

Local Institution, Nagoya, Aichi

Local Institution, Kashiwa, Chiba

Local Institution, Kanazawa-shi, Ishikawa

Local Institution, Yokohama-Shi, Kanagawa

Local Institution, Yokohama-shi, Kanagawa

Local Institution, Natori-shi, Miyagi

Local Institution, Sendai, Miyagi

Local Institution, Kurashiki-shi, Okayama

Local Institution, Hirakata-shi, Osaka

Local Institution, Osaka-shi, Osaka

Local Institution, Sunto-gun, Shizuoka

Local Institution, Chuo-ku, Tokyo

Local Institution, Ube-shi, Yamaguchi

Local Institution, Akashi, Hyogo, Not set

Local Institution, Fukuoka, Not set

Local Institution, Matsuyama, Ehime, Not set

Local Institution, Osakasayama-city, Not set

Local Institution, Sapporo Hokkaido, Not set

Local Institution, Sapporo, Hokkaido, Not set

Local Institution, Sendai, Miyagi, Not set

Local Institution, Takatsuki, Not set

Local Institution, Tokyo, Not set

Local Institution, Cheonju-si, Chungcheongbuk-do

Local Institution, Goyang-si, Gyeonggi-do

Local Institution, Suwon-si, Gyeonggi-do

Local Institution, Seoul, Kangnam-gu

Local Institution, Seoul, Seodaemungu

Local Institution, Busan, Not set

Local Institution, Daegu, Not set

Local Institution, Gyeonggi-do, Not set

Local Institution, Seoul, Not set

Local Institution, Suwon, Not set

Local Institution, Mexico, Distrito Federal

Local Institution, Zapopan, Jalisco

Local Institution, Monterrey, Nuevo LEON

Local Institution, Breda, Not set

Local Institution, Harderwijk, Not set

Local Institution, Hertogenbosch, Not set

Local Institution, Nieuwegein, Not set

Local Institution, Trujillo, LA Libertad

Local Institution, Arequipa, Not set

Local Institution, Cercado, Not set

Local Institution, Lima, Not set

Local Institution, Elblag, Not set

Local Institution, Gdansk- Zaspa, Not set

Local Institution, Gdansk, Not set

Local Institution, Grudziadz, Not set

Local Institution, Olsztyn, Not set

Local Institution, Otwock, Not set

Local Institution, Poznan, Not set

Local Institution, Szczecin, Not set

Local Institution, Torun, Not set

Local Institution, Warsaw, Not set

Local Institution, Sao Martinho Do Bispo, Coimbra

Local Institution, Lisboa, Not set

Local Institution, Porto, Not set

Local Institution, Santa Maria Da Feira, Not set

Local Institution, Vila Nova De Gaia, Not set

Local Institution, Bucharest, Not set

Local Institution, Bucuresti, Not set

Local Institution, Cluj Napoca, Not set

Local Institution, Sibiu, Not set

Local Institution, Suceava, Not set

Local Institution, Timisoara, Not set

Local Institution, Chelyabinsk, Not set

Local Institution, Kazan, Not set

Local Institution, Moscow, Not set

Local Institution, Pyatigorsk, Not set

Local Institution, Saint Petersburg, Not set

Local Institution, St-Peterburg, Not set

Local Institution, St. Petersburg, Not set

Local Institution, Tula, Not set

Local Institution, Singapore, Not set

Local Institution, Vereeniging, Gauteng

Local Institution, Panorama,cape Town, Western CAPE

Local Institution, Cape Town, Not set

Local Institution, Durban, Not set

Local Institution, Barakaldo, Vizcaya

Local Institution, Avila, Not set

Local Institution, Benidorm-alicante, Not set

Local Institution, Castellon, Not set

Local Institution, Madrid, Not set

Local Institution, Manresa, Not set

Local Institution, Ourense, Not set

Local Institution, Valencia, Not set

Local Institution, Gothenburg, Not set

Local Institution, Lund, Not set

Local Institution, Stockholm, Not set

Local Institution, Umea, Not set

Local Institution, Basel, Not set

Local Institution, Winterthur, Not set

Local Institution, Changhua City, Not set

Local Institution, Chiayi, Not set

Local Institution, Kaohsiung County, Not set

Local Institution, Taichung, Not set

Local Institution, Taipei City, Not set

Local Institution, Taipei, Not set

Local Institution, Bangkok, Tungpayathai

Local Institution, Bangkok, Not set

Local Institution, Chiang Mai, Not set

Local Institution, Songkhla, Not set

Local Institution, Dundee, Angus/forfarshire

Local Institution, Truro, Cornwall

Local Institution, Southampton, Hampshire

Local Institution, Nottingham, Not set

Local Institution, Sheffield, Not set

Conditions: Lung Cancer - Non Small Cell Squamous

Learn More ›

A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer

NCT02514551

Completed

The main purpose of this study is to evaluate the efficacy of an alternative dose of ramucirumab in combination with paclitaxel in participants with second-line metastatic or locally advanced, unresectable gastric or gastroesophageal junction adenocarcinoma (GEJ).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/10/2020

Locations: City of Hope National Medical Center, Duarte, California +51 locations

City of Hope National Medical Center, Duarte, California

University of Kansas Medical Center, Westwood, Kansas

Dana Farber Cancer Institute, Boston, Massachusetts

Montefiore Medical Center, Bronx, New York

Weill Cornell Medical College, New York, New York

Scott & White Memorial Hospital & Clinic, Temple, Texas

Vista Oncology Inc. PS, Olympia, Washington

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Brussels, Not set

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Calgary, Not set

Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

Learn More ›

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

NCT03704077

Withdrawn

The purpose of this study is to determine the effectiveness of relatlimab plus nivolumab, alone or in combination with various standard-of-care treatments in participants with gastric cancer (GC) or gastroesophageal junction (GEJ) adenocarcinoma that has come back or spread to other places in the body after prior therapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/17/2020

Locations: Local Institution, Daphne, Alabama +83 locations

Local Institution, Daphne, Alabama

Local Institution, Bakersfield, California

Local Institution, Fullerton, California

Local Institution, Los Angeles, California

Local Institution, Redondo Beach, California

Local Institution, Santa Barbara, California

Local Institution, Aurora, Colorado

Local Institution, Lakewood, Colorado

Local Institution, Miami, Florida

Local Institution, Tampa, Florida

Local Institution, Marietta, Georgia

Local Institution, Boston, Massachusetts

Local Institution, Saint Louis, Missouri

Local Institution, New Brunswick, New Jersey

Local Institution, Chapel Hill, North Carolina

Local Institution, Charlotte, North Carolina

Local Institution, Fargo, North Dakota

Local Institution, Allentown, Pennsylvania

Local Institution, Sioux Falls, South Dakota

Local Institution, Vancouver, Washington

Local Institution, Viedma, RIO Negro

Local Institution, Buenos Aires, Not set

Local Institution, Caba, Not set

Local Institution, Ciudad Autonoma de Buenos Aires, Not set

Local Institution, Cordoba, Not set

Local Institution, Westmead, New South Wales

Local Institution, Heidelberg, Victoria

Local Institution, Malvern, Victoria

Local Institution, Melbourne, Victoria

Local Institution, Bedford Park, Not set

Local Institution, Murdoch, Not set

Local Institution, Fortaleza, Ceara

Local Institution, Belo Horizonte, Minas Gerais

Local Institution, Porto Alegre, RIO Grande DO SUL

Local Institution, Barretos, SAO Paulo

Local Institution, Jau, SAO Paulo

Local Institution, Rio de Janeiro, Not set

Local Institution, Sao Paulo, Not set

Local Institution, Halifax, Nova Scotia

Local Institution, Hamilton, Ontario

Local Institution, Ottawa, Ontario

Local Institution, Toronto, Ontario

Local Institution, Montreal, Quebec

Local Institution, Sherbrooke, Quebec

Local Institution, Santiago, Metropolitana

Local Institution, Medellin, Not set

Local Institution, Berlin, Not set

Local Institution, Cologne, Not set

Local Institution, Erlangen, Not set

Local Institution, Essen, Not set

Local Institution, Frankfurt am Main, Not set

Local Institution, Freiburg, Not set

Local Institution, Hamburg, Not set

Local Institution, Hannover, Not set

Local Institution, Jena, Not set

Local Institution, Mainz, Not set

Local Institution, Mannheim, Not set

Local Institution, Marburg, Not set

Local Institution, Paderborn, Not set

Local Institution, Reutlingen, Not set

Local Institution, Wiesbaden, Not set

Local Institution, Bergamo, Not set

Local Institution, Milano, Not set

Local Institution, Napoli, Not set

Local Institution, Reggio Emilia, Not set

Local Institution, Tuxtla Gutierrez, Chiapas

Local Institution, Mexico City, Distrito Federal

Local Institution, ZONA Centro. LEON, Guanajuato

Local Institution, Merida, Yucatan

Local Institution, Aguascalientes, Not set

Local Institution, Lisboa, Not set

Local Institution, Porto, Not set

Local Institution, Rio Piedras, Not set

Local Institution, Bucuresti, Not set

Local Institution, Cluj-Napoca, Not set

Local Institution, Craiova, Not set

Local Institution, Floresti, Not set

Local Institution, Badajoz, Not set

Local Institution, Madrid, Not set

Local Institution, Valencia, Not set

Conditions: Gastric Cancer, Cancer of the Stomach, Stomach Cancer, Gastroesophageal Junction

Learn More ›

Combination Chemotherapy in Treating Patients With Breast Cancer

NCT00003088

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs at different times or combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy consisting of either doxorubicin, cyclophosphamide, or paclitaxel given at different times with that of combination chemoth... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

04/28/2020

Locations: CCOP - Scottsdale Oncology Program, Scottsdale, Arizona +18 locations

Conditions: Breast Cancer

Learn More ›

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

NCT00006229

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel and carboplatin are more effective with or without BMS-275291 for non-small cell lung cancer. PURPOSE: Randomized phase II/III trial to compare the effectiveness of paclitaxel and carboplatin with or without BMS-275291 in treating patients who have advanced or metastatic non-small cell lung cancer.

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

04/02/2020

Locations: University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama +68 locations

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Scripps Clinic, La Jolla, California

Central Georgia Hematology Oncology, P.C., Macon, Georgia

Queen's Medical Center, Honolulu, Hawaii

Carle Cancer Center, Urbana, Illinois

Lahey Clinic - Burlington, Burlington, Massachusetts

Creighton University Cancer Center, Omaha, Nebraska

Duke University Medical Center, Durham, North Carolina

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Erlanger Health Systems, Chattanooga, Tennessee

Memorial Hospital Cancer Center - Chattanooga, Chattanooga, Tennessee

Williamson Medical Center, Franklin, Tennessee

Jackson-Madison County General Hospital, Jackson, Tennessee

Baptist Regional Cancer Center - Knoxville, Knoxville, Tennessee

Saint Thomas Hospital, Nashville, Tennessee

Meharry Medical College, Nashville, Tennessee

Division of Medical Oncology - Vanderbilt, Nashville, Tennessee

AKH Vienna, Vienna (Wien), Not set

Allgemeines Krankenhaus der Stadt Wien, Vienna (Wien), Not set

Universiteit Gent, Gent, Not set

Centre Hospitalier Regional de la Citadelle, Liege (Luik), Not set

Algemeen Ziekenhuis Sint-Augustinus, Wilrijk, Not set

Cross Cancer Institute, Edmonton, Alberta

CancerCare Manitoba, Winnipeg, Manitoba

Nova Scotia Cancer Centre, Halifax, Nova Scotia

Royal Victoria Hospital, Barrie, Barrie, Ontario

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario

Ottawa Regional Cancer Centre, Ottawa, Ontario

Peterborough Oncology Clinic, Peterborough, Ontario

Algoma District Medical Group, Sault Sainte Marie, Ontario

Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines, Ontario

Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario

Mount Sinai Hospital - Toronto, Toronto, Ontario

Toronto General Hospital, Toronto, Ontario

Saint Joseph's Health Centre - Toronto, Toronto, Ontario

Humber River Regional Hospital, Weston, Ontario

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor, Ontario

Allan Blair Cancer Centre, Regina, Saskatchewan

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Helsinki University Central Hospital, Helsinki, Not set

CHR de Besancon - Hopital Jean Minjoz, Besancon, Not set

Hopital Avicenne, Bobigny, Not set

CHR de Grenoble - La Tronche, Grenoble, Not set

CRLCC Nantes - Atlantique, Nantes-Saint Herblain, Not set

Hopital de Neuhof, Strasbourg, Not set

Institut Claudius Regaud, Toulouse, Not set

Centre Hospitalier Universitaire Bretonneau de Tours, Tours, Not set

Stadisches Krankenhaus Martha Maria Halle-Dolau, Halle, Not set

Allgemeines Krankenhaus, Hamburg, Not set

Lungenklinik Hemer, Hemer, Not set

Marienhospital/Ruhr University Bochum, Herne, Not set

Klinikum Rechts Der Isar/Technische Universitaet Muenchen, Munich (Muenchen), Not set

Oncologia Medica - Perugia, Perugia, Not set

Ospedale San Filippo Neri, Rome, Not set

Ospedale Carlo Forlanini, Rome, Not set

Istituto Clinico Humanitas, Rozzano (MI), Not set

Ospedale Civile San Giovanni e Paolo, Venezia, Not set

Academisch Ziekenhuis Maastricht, Maastricht, Not set

Medical University of Gdansk, Gdansk, Not set

Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Marques de Valdecilla, Santander, Not set

Servicio De Oncologia, Valencia, Not set

Kantonspital Aarau, Aarau, Not set

Inselspital, Bern, Bern, Not set

Universitaetsspital, Zurich, Not set

Charing Cross Hospital, London, England

Chelsea Westminster Hospital, London, Not set

Conditions: Lung Cancer

Learn More ›

Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

NCT00028743

Completed

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different combinations may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective in treating ovarian epithelial, primary peritoneal, or fallopian tube cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of different combination chemotherapy regimens in treati... Read More

Gender:

FEMALE

Ages:

Between 18 years and 75 years

Trial Updated:

03/31/2020

Locations: Tom Baker Cancer Centre, Calgary, Alberta +27 locations

Tom Baker Cancer Centre, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia

Lions Gate Hospital, North Vancouver, British Columbia

BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia

BCCA - Vancouver Cancer Centre, Vancouver, British Columbia

CancerCare Manitoba, Winnipeg, Manitoba

The Moncton Hospital, Moncton, New Brunswick

Atlantic Health Sciences Corporation, Saint John, New Brunswick

Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador

QEII Health Sciences Center, Halifax, Nova Scotia

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario

Cancer Centre of Southeastern Ontario at Kingston, Kingston, Ontario

Grand River Regional Cancer Centre, Kitchener, Ontario

London Regional Cancer Program, London, Ontario

Ottawa Health Research Institute - General Division, Ottawa, Ontario

Niagara Health System, St. Catharines, Ontario

Northeast Cancer Center Health Sciences, Sudbury, Ontario

Thunder Bay Regional Health Science Centre, Thunder Bay, Ontario

Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario

Windsor Regional Cancer Centre, Windsor, Ontario

PEI Cancer Treatment Centre,Queen Elizabeth Hospital, Charlottetown, Prince Edward Island

CHUM - Hopital Notre-Dame, Montreal, Quebec

Hopital du Sacre-Coeur de Montreal, Montreal, Quebec

CHUQ-Pavillon Hotel-Dieu de Quebec, Quebec City, Quebec

Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec

Allan Blair Cancer Centre, Regina, Saskatchewan

Saskatoon Cancer Centre, Saskatoon, Saskatchewan

Conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer

Learn More ›

Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors

NCT01653470

Completed

The purpose of this study is to identify a safe and tolerable dose of BMS-906024 in combination with each of the following three chemotherapy regimens: Paclitaxel, 5FU plus Irinotecan (FOLFIRI), or Carboplatin plus Paclitaxel in subjects with advanced or metastatic solid tumors

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/24/2020

Locations: Usc/Norris Comprehensive Cancer Center, Los Angeles, California +4 locations

Conditions: Cancer

Learn More ›

Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors

NCT01962103

Completed

The purpose of this study is to find the safe dose of nab-paclitaxel in children with solid tumors, and to see if it works to treat these solid tumors in children and young adults (in Phase 1 ≤ 18 years old and in Phase 2 ≤ 24 years old). After the final dose has been chosen, patients will be enrolled according to the specific solid tumor type, (neuroblastoma, rhabdomyosarcoma, or Ewing's sarcoma), to see how nab-paclitaxel works in treating these tumors.

Gender:

ALL

Ages:

Between 6 months and 24 years

Trial Updated:

12/19/2019

Locations: Phoenix Childrens Hospital, Phoenix, Arizona +19 locations

Conditions: Neuroblastoma, Rhabdomyosarcoma, Ewing's Sarcoma, Ewing's Tumor, Sarcoma, Ewing's, Sarcomas, Epitheliod, Sarcoma, Soft Tissue, Sarcoma, Spindle Cell, Melanoma, Malignant Melanoma, Clinical Oncology, Oncology, Medical, Pediatrics, Osteosarcoma, Osteogenic Sarcoma, Osteosarcoma Tumor, Sarcoma, Osteogenic, Tumors, Cancer, Neoplasia, Neoplasm, Histiocytoma, Fibrosarcoma, Dermatofibrosarcoma

Learn More ›

First Line Therapy for Patients With Metastatic Breast Cancer

NCT00456846

Terminated

The purpose of this study is to determine the toxicity and anti-tumor activity of nab-paclitaxel 100mg/m\^2 administered weekly in a 4-week cycle as first line therapy to patients with metastatic breast cancer who received taxanes as part of their adjuvant therapy and patients who did not receive taxanes as part of their adjuvant therapy.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

11/07/2019

Locations: BC Cancer Agency-Burnaby, Burnaby, British Columbia +13 locations

Conditions: Metastatic Breast Cancer

Learn More ›

Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas

NCT00844649

Completed

Phase III Metastatic Pancreatic Cancer

Gender:

ALL

Ages:

Between 18 years and 79 years

Trial Updated:

11/07/2019

Locations: UAB Comprenhensive Cancer Center at University of Alabama, Birmingham, Alabama +192 locations

UAB Comprenhensive Cancer Center at University of Alabama, Birmingham, Alabama

Clearview Cancer Institute Oncology Specialities, P.C., Huntsville, Alabama

TGEN Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona

Mayo Clinic-Scottsdale, Scottsdale, Arizona

Northern Arizona Hematology and Oncology Associates-AOA, Sedona, Arizona

Arizona Cancer Center, University of Arizona, Tucson, Arizona

Genesis Cancer Center, Hot Springs, Arkansas

Tower Cancer Research Foundation, Beverly Hills, California

City of Hope, Duarte, California

Pacific Shores Medical Group, Long Beach, California

UCLA, Los Angeles, California

Desert Hematology Oncology Medical Group, Inc., Rancho Mirage, California

University of Colorado Cancer Center, Aurora, Colorado

Rocky Mountain Cancer Center, Denver, Colorado

University Cancer Institute, LLC, Boynton Beach, Florida

Collaborative Research Group, Boynton Beach, Florida

FL Cancer Specialist, Fort Myers, Florida

Lakeland Regional Cancer Center, Lakeland, Florida

Ocala Oncology Center, Ocala, Florida

Florida Hospital Cancer Institute, Orlando, Florida

Lake County Oncology and Hematology, Tavares, Florida

Phoebe Putney Cancer Center, Albany, Georgia

Northeast Georgia Cancer Care, LLC, Athens, Georgia

Piedmont Hospital Research Institute, Atlanta, Georgia

Georgia Cancer Specialists, Atlanta, Georgia

Atlanta Cancer Care, Atlanta, Georgia

Cancer Care & Hemaotology Specialists of Chicagoland, Arlington Heights, Illinois

NorthShore University HealthSystem, Evanston, Illinois

Cancer Care & Hematology Specialists of Chicagoland, Niles, Illinois

Illinois Cancer Care, Peoria, Illinois

Orchard Research, Skokie, Illinois

Indiana University Simon Cancer Center, Indianapolis, Indiana

Hutchinson Clinic, PA, Hutchinson, Kansas

Owsley Brown Frazier Cancer Center, Louisville, Kentucky

Hematology Oncology Clinic, Baton Rouge, Louisiana

Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana

Central Maine Medical Center, Lewiston, Maine

Mercy Hospital Portland, ME, Portland, Maine

Maine Center for Cancer Medicine, Scarborough, Maine

Sidney Kimmel Comphrensive Cancer Center, John Hopkins University, Baltimore, Maryland

Center for Cancer & Blood Disorders, Bethesda, Maryland

Lahey Clinic, Burlington, Massachusetts

Cancer Center of Excellence/University of MA Medical School, Worcester, Massachusetts

St. Mary's/ Duluth Clinic, Duluth, Minnesota

Virginia Piper Cancer Institute, Minneapolis, Minnesota

University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota

Saint Louis University, Saint Louis, Missouri

St. John's Medical Research Institute, Springfield, Missouri

The Center for Cancer and Hematologic Disease, Cherry Hill, New Jersey

Hem Onc Associates-NM, Albuquerque, New Mexico

University of New Mexico, Albuquerque, New Mexico

New York Oncology Hematology PC, Albany, New York

Roswell Park Cancer Institute, Buffalo, New York

Arena Oncology Associates, PC, Lake Success, New York

SUNY Upstate Medical University, Syracuse, New York

Piedmont Hematology Oncology, Winston-Salem, North Carolina

Oncology Hematology Care, Cincinnati, Ohio

Mid Ohio Oncology/Hematology Inc, Columbus, Ohio

Kettering Medical Center, Kettering, Ohio

Signal Point Clinical Research Center, LLC, Middletown, Ohio

Cancer Centers of SW OK, Lawton, Oklahoma

University of Oklahoma Health Science Center, Oklahoma City, Oklahoma

Mercy Physicians of Oklahoma, Oklahoma City, Oklahoma

Cancer Care Associates- Tulsa, Tulsa, Oklahoma

St. Mary Medical Center Hem-Onc Group, PC, Langhorne, Pennsylvania

University of Pittsburg Medical Center, Pittsburgh, Pennsylvania

South Carolina Oncology Associates, Columbia, South Carolina

Chattanooga Oncology Hematology Associates, Chattanooga, Tennessee

Tennessee Oncology, Nashville, Tennessee

Medical City Dallas-US Oncology, Dallas, Texas

Texas Oncology, PA, Dallas, Texas

Texas Oncology, PA/ Methodist Charlton Cancer Center, Dallas, Texas

Texas Oncology Laboratories, Fort Worth, Texas

The Center for Cancer and Blood Disorders, Fort Worth, Texas

The University of Texas Medical School at Houston, Houston, Texas

Texas Oncology- Plano East, Plano, Texas

Texas Oncology, PA, Round Rock, Texas

Texas Oncology-Round Rock, Round Rock, Texas

South Texas Oncology and Hematology, P.A, San Antonio, Texas

Texas Oncology, PA, Wichita Falls, Texas

Utah Cancer Specialists, Salt Lake City, Utah

Huntsman Cancer Institute, Salt Lake City, Utah

Fairfax-Northern Virginia Hematology-Oncology, P.C., Fairfax, Virginia

Virginia Cancer Specialist, PC, Fairfax, Virginia

Virginia Cancer Institute, Richmond, Virginia

Virginia Commonwealth University, Richmond, Virginia

Swedish Health Services, Seattle, Washington

Fred Hutchinson Cancer Research Center, Seattle, Washington

Evergreen Hematology & Oncology, Spokane, Washington

Medical College of Wisconsin, Milwaukee, Wisconsin

Bankstown-Lidcombe Hospital, Bankstown, New South Wales

Macarthur Cancer Therapy Center, Campbelltown, New South Wales

Concord Hospital, Concord, New South Wales

St. Vincent's Hospital, Darlinghurst, New South Wales

Prince of Wales Hospital, Randwick, New South Wales

Newcastle Hospital, Waratah, New South Wales

Southern Medical Day Care Centre, Wollongong, New South Wales

Royal Brisbane and Women's Hospital, Herston, Queensland

Haemotology & Oncology Australasia (HOCA), Milton, Queensland

Haematology Oncology Clinics of Australasia-Gold Coast, Milton, Queensland

Adelaide Cancer Centre (T/A Ashford Cancer Ctr), Ashford, South Australia

Flinders Medical Center, Bedford Park, South Australia

Calvary North Adelaide Hospital, North Adelaide, South Australia

Royal Hobart Hospital, Hobart, Tasmania

Medical Oncology Unit, Bendigo Health, Bendigo, Victoria

Monash Medical Centre, East Bentleigh, Victoria

Western Hospital, Footscray, Victoria

Peninsula Oncology Centre, Frankston, Victoria

Alfred Hospital, Melbourne, Victoria

Border Medical Oncology, Wodonga, Victoria

Sir Charles Gairdner Hospital, Nedlands, Perth, Western Australia

Krankenhaus der Barmherzigen Schwestern Linz, Linz, Not set

Landesklinikum St. Pölten, St. Pölten, Not set

Medizinische Universität Wien, Vienna, Not set

Klinikum Wels-Grieskirchen GmbH, Wels, Not set

Imelda VZW , Gastro-Enterology, Bonheiden, Not set

Hôpital Erasme, Gastro-Enterology, Brussels, Not set

AZ Groeninge - Campus Sint-Niklaas, Kortrijk, Not set

H.-Hartziekenhuis Roeselare-Menen vzw, Roeselare, Not set

Tom Baker Cancer Centre, Calgary, Alberta

BC Cancer Agency-Vancouver, Vancouver, British Columbia

The Royal Victoria Hospital-Barrie, Barrie, Ontario

Hopital du Sacre-Coeur, Montreal, Quebec

Centre Hospitalier de L'Universite de Montreal St-Luc, Montreal, Not set

Princess Margaret Hospital, Ontario, Not set

Hotel-Dieu de Quebec, Quebec, Not set

Centre Regional de lutte contre le cancer Paul Papin, Angers, Not set

Hôpital Saint Antoine, Paris, Not set

Hôpital Beaujon, Paris, Not set

Kliniken Essen-Mitte, Essen, Not set

Klinikum Freising, Freising, Not set

Praxis für Innere Medizin, Dr. Oettle Helmut, Friedrichshafen, Not set

LMU Klinikum der Universität, Munich, Not set

Klinikum Oldenburg, Oldenburg, Not set

Universitätsklinikum Würzburg, Würzburg, Not set

I.R.C.C.S. "Giovanni Paolo II" - Istituto Oncologico, Bari, Not set

E. O. Ospedali Galliera, Struttura Complessa Oncologia Medica, Genova, Not set

Nazionale per la Ricerca sul Cancro, Genova, Not set

Fondazione Centro San Raffaele del Monte Tabor, Milano, Not set

Oncologia Medica Falck, Milano, Not set

Istituto Oncologico Veneto, Padova, Not set

IRCCS Policlinico San Matteo, Pavia, Not set

Azienda Ospedaliero universitaria Pisana, Pisa, Not set

Arcispedale Santa Maria Nuova, Unità Operativa di Oncologia Medica, Reggio Emilia, Not set

Arcispedale Santa Maria Nuova, Reggio Emilia, Not set

Istituto Nazionale Tumori "Regina Elena", Roma, Not set

Istituto Clinico Humanitas, Rozzano, Not set

Ospedale Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo, Foggia, Not set

Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Not set

Med Radiological Centre of the Russian Academy of Med Sciences, Obninsk, Kaluga Region

Tatarstan Republican Onc Ctr, Kazan, Republic Of Tatarstan

Altai Territorial Oncological Center, Barnaul, Not set

Chelyabinsk Regional Onc Ctr, Chelyabinsk, Not set

Ivanovo Regional Oncology Center, Ivanovo, Not set

Regional Oncological Center # 2, Magnitogorsk, Not set

Moscow Municipal Onc Hosp #62, Moscow Region, Not set

Moscow City Clinical Hosp #57 Chemotherapy Dept, Moscow, Not set

Blokhin Cancer Research Center, Moscow, Not set

Russian Res Ctr of Radiology under the Fed Agency for Hi-Tech Med Care, Moscow, Not set

Russian Research Ctr of Surgery n.a. B.V. Petrovskiy under the Russian Academy of Med Sciences, Moscow, Not set

Central Clinical Hosp of the President of the Russian Federation, Moscow, Not set

Semashko Central Hosp #2, Moscow, Not set

Omsk Regional Onc Ctr, Omsk, Not set

Orenburg Regional Onc Ctr, Orenburg, Not set

Pyatigorsk Affiliate of Stavropol Regional Onc Ctr, Pyatigorsk, Not set

St. Petersburg State Med Academy n.a.Mechnikov, St Petersburg, Not set

Russian Research Ctr for Radiology and Surgical Technologies, St Petersburg, Not set

Clinical Hosp # 122 n.a. L.G. Sokolov, St. Petersburg, Not set

Leningrad Regional Clinical Hosp, St. Petersburg, Not set

St. Petersburg City Onc Ctr, St. Petersburg, Not set

Tula Regional Oncology Center, Tula, Not set

Bashkortostan Republican Onc Ctr, Ufa, Not set

Yaroslavl Regional Onc Ctr, Yaroslavl, Not set

Hospital Vall D´Hebron, Barcelona, Not set

Hospital Clinic i Provincial, Barcelona, Not set

Hospital Universitario Reina Sofia, Córdoba, Not set

Hospital Universitario Ramón y Cajal, Madrid, Not set

Hospital Clinico San Carlos, Madrid, Not set

Hospital 12 de Octubre, Madrid, Not set

Centro Integral Oncológico Clara Campal, Madrid, Not set

Hospital Virgen del Rocio, Sevilla, Not set

Dnepropetrovsk City Hosp #4, Dnepropetrovsk, UK

Donetsk Regional Antitumor Ctr, Donetsk, UK

Kirovohrad Regional Oncology Center, Department of Chemotherapy, Kirovohrad, UK

National Institute of Cancer, Department of Tumors of Abdominal Cavity and Retroperitoneum, Kyiv, UK

Kyiv City Clinical Hospital #10, Center for Hepatic, Bile Duct and Pancreatic Surgery, Kyiv, UK

Volyn Regional Oncology Center Department of Oncochemotherapy, Lutsk, UK

Lviv Regional Diagnostics and Treatment and Diagnostics Onc Ctr, Lviv, UK

O.F. Herbachevskyi Regional Clinical Hospital, Surgery Center, Zhytomyr, UK

Kharkov Regional Onc Ctr, Kharkov, Not set

Kherson Regional Onc Ctr, Kherson, Not set

Odessa Regional Onc Ctr, Odessa, Not set

Zaporizhia Medical Academy of Postgraduate Education, Zaporizhia, Not set

Conditions: Metastatic Pancreatic Cancer

Learn More ›

A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

NCT02021500

Completed

A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.

Gender:

ALL

Ages:

All

Trial Updated:

10/30/2019

Locations: TGen Clinical Research Services, Scottsdale, Arizona +38 locations

TGen Clinical Research Services, Scottsdale, Arizona

Mayo Clinic, Scottsdale, Arizona

Pacific Shores Medical Group, Long Beach, California

University of Colorado Cancer Center, Aurora, Colorado

Florida Cancer Specialists, Englewood, Florida

Florida Cancer Specialist, Tavares, Florida

Indiana University, Indianapolis, Indiana

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts

Arena Oncology Associates, Lake Success, New York

UPMC Cancer Pavillion, Pittsburgh, Pennsylvania

Tennessee Oncology PLLC, Nashville, Tennessee

South Texas Oncology and Hematology (STOH), San Antonio, Texas

Fairfax-Northern Virginia Haematology-Oncology, Fairfax, Virginia

Virginia Cancer Institute, Richmond, Virginia

Fred Hutchinson Cancer Research Center, Seattle, Washington

Froedtert and Medical College ID Clinic, Milwaukee, Wisconsin

Macarthur Cancer Therapy Centre, Campbelltown, New South Wales

Prince of Wales Hospital, Randwick, New South Wales

HOCA - the Wesley Clinic for Heamatology and Oncology, Auchenflower, Queensland

Mater Medical Center, South Brisbane, Not set

Landesklinikum St. Pölten, St. Pölten, Not set

Medizinische Universität Wien, Vienna, Not set

Klinikum Wels-Grieskirchen GmbH, Wels, Not set

Tom Baker Cancer Centre, Calgary, Alberta

British Columbia Cancer Agency, Vancouver, British Columbia

Royal Victoria Regional Health Centre, Barrie, Ontario

Centre Hospsitalier Universitaire de Montreal - Notre Dame, Montreal, Quebec

Hôpital Beaujon, Clichy, Not set

Hôpital Saint Antoine, Paris, Not set

Kliniken Essen-Mitte, Essen, Not set

LMU Klinikum der Universität München, Munchen, Not set

Ospedale San Raffaele S.r.l., Milano, Not set

Azienda Ospedaliera Niguarda Cà Granda, Milano, Not set

Ospedale Casa Sollievo Della Sofferenza IRCCS, San Giovanni Rotundo, Not set

Azienda Ospedaliera Universitaria Integrata Di Verona, Verona, Not set

Hospital Universitari Vall d'Hebron, Barcelona, Not set

Hospital Clinico San Carlos, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Municipal institution Multifield City Clinical Hospital #4 of Dnipropetrovsk Regional Council, Dnipropetrovsk, Not set

Conditions: Pancreatic Cancer

Learn More ›

Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer

NCT00540514

Completed

The purpose of this study is to compare disease response of Albumin-bound paclitaxel (ABI-007) plus Carboplatin versus Taxol and Carboplatin as first-line therapy in patients with advanced non-small cell lung cancer (NSCLC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/16/2019

Locations: Clearview Cancer Institute Oncology Specialties, P.C., Huntsville, Alabama +36 locations

Clearview Cancer Institute Oncology Specialties, P.C., Huntsville, Alabama

Genesis Cancer Center- Hot Springs, Hot Springs, Arkansas

Little Rock Hematology Oncology Associates, Little Rock, Arkansas

Pacific Cancer Medical Center, Inc., Anaheim, California

Comprehensive Blood and Cancer Center, Bakersfield, California

Southwest Cancer Care, Escondido, California

Robert A. Moss, MD, FACP, Inc., Fountain Valley, California

Pacific Shores Medical Group, Long Beach, California

Ventura County Hematology-Oncology Specialists, Oxnard, California

Comprehensice Cancer Ctr., Palms Springs, California

Gulf Coast Oncology Associates, Saint Petersburg, Florida

Lake County Oncology and Hematology, PA, Tavares, Florida

Phoebe Cancer Center, Albany, Georgia

Cancer Center of Kansas, Wichita, Kansas

Kentuckiana Cancer Institute, PLLC, Louisville, Kentucky

Mercy Hospital, Portland, Maine

Maine Center for Cancer Medicine, Scarborough, Maine

Mercy Medical Center, Baltimore, Maryland

St. Louis University, Saint Louis, Missouri

Essex Oncology of North Jersey, Belleville, New Jersey

Mary Imogene Bassett Hospital, Cooperstown, New York

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

St. Mary Medical Center- Oncology, Hematology PC, Langhorne, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

Dallas Oncology Consultants, PA, Duncanville, Texas

The Center for Cancers and Blood Disorders, Fort Worth, Texas

Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas

Blood and Cancer Center of East Texas, Tyler, Texas

Tyler Hematology Oncology, Tyler, Texas

Fletcher Allen Health Care, Burlington, Vermont

Cancer Outreach Associates, PC, Abingdon, Virginia

Royal Columbian Hospital, New Westminster, British Columbia

William Osler Health Centre, Brampton Clinic, Brampton, Ontario

Toronto East General Hospital, Toronto, Ontario

Princess Margaret Hospital, Toronto, Ontario

McGill University- Dept. of Oncology, Montreal, Quebec

Hopital du Sacre-Coeur de Montreal, Montreal, Quebec

Conditions: Non-Small Cell Lung Carcinoma

Learn More ›